Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
News
Ars Technica
Moderna’s mRNA flu shot earns FDA approval after rollercoaster review - Ars Technica
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account